35Pharma

Montreal, Canada · Founded 2021 · Acquired/Merged (Operating Subsidiary)

Operator of a biopharmaceutical company intended for pulmonary hypertension and musculoskeletal disorders. 35Pharma is based in Montreal, Canada and was founded in 2021. Its last known valuation is $950 million (Apr 2026). It has raised $70 million.

Last price · $/share
—
Implied valuation
$950.0M
Total raised
$70.0M
Last round
—

Who backs 35Pharma?

10 investors
InvestorType
Logos CapitalHedge fund
Frazier Healthcare PartnersVenture capital
Marshall WaceHedge fund
Vivo CapitalVenture capital
Surveyor CapitalHedge fund
Deep Track CapitalVenture capital
venBioVenture capital
Columbia ManagementAsset manager
Paradigm BioCapitalHedge fund
Janus Henderson Investors—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

35Pharma investors

10 investors are on record for 35Pharma, including Logos Capital, Frazier Healthcare Partners, Marshall Wace and Vivo Capital. By type, the record holds 4 venture capital firms, 4 hedge funds and 1 asset manager.

Free account
More of 35Pharma with a free account
  • ·Watch 35Pharma: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 10 firms already write checks for companies like 35Pharma. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View